J. V. Meerloo

Resistance to crizotinib in a cMET gene amplified tumor cell line is associated with impaired sequestration of crizotinib in lysosomes

E. Giovannetti, G. Peters, P. Pauwels, 2018 .

Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells

Y. Assaraf, A. Schimmer, G. Jansen, 2012, Leukemia.

Sensitivity of Pediatric Acute Leukemia Cells to Bortezomib and Epoxyketone-Based Proteasome Inhibitors: Correlations with Proteasome Subunit Expression

Y. Assaraf, G. Jansen, J. Cloos, 2011 .